NanoViricides CEO Discusses Groundbreaking Broad-spectrum Antiviral Treatment | NYSE-A:NNVC

Proactive InvestorsJan 7 08:34 ET

NanoViricides Is in a Great Position to Fight Potential Bird Flu Pandemic With a Drug That the Mercurial H5N1 Influenza A Virus Is Unlikely to Escape

AccesswireDec 23, 2024 06:30 ET

The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA

Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.

wallstreetcnDec 8, 2024 22:05 ET

NanoViricides CEO Highlights Urgency of H5N1 Preparedness as Cases Rise in North America | NYSE-A:NNVC

Proactive InvestorsDec 6, 2024 13:10 ET

Trump Nominates Marty Makary For FDA Commissioner

Barron'sNov 22, 2024 22:27 ET

The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17, 2024 07:00 ET